Gemcitabine-mediated tumour regression and p53-dependent gene expression: implications for colon and pancreatic cancer therapy

R. Hill, M. Rabb, P. A. Madureira, D. Clements, S. A. Gujar, D. M. Waisman, C. A. Giacomantonio, P. W. K. Lee

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Gemcitabine-mediated tumour regression and p53-dependent gene expression: implications for colon and pancreatic cancer therapy'. Together they form a unique fingerprint.

    INIS

    Pharmacology, Toxicology and Pharmaceutical Science